Çağlar Ünal

Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer

Ullrich Graeven, B. Kremer, Th Südhoff et al. · British Journal of Cancer · 2006 · 99 citations · Full text

The real‐world outcomes of Lutetium‐177 PSMA‐617 radioligand therapy in metastatic castration‐resistant prostate cancer: Turkish Oncology Group multicenter study

Elvina Almuradova, Mustafa Seyyar, Hacı Arak et al. · International Journal of Cancer · 2023 · 22 citations · Full text

Urology, Radiation Medicine, Lu-177 Psma-617 Rlt +13

The relationship between psychological flexibility, self-compassion, and posttraumatic growth in cancer patients in the COVID-19 pandemic

İpek Özönder Ünal, Çağlar Ünal, Tomris Duymaz · Supportive Care in Cancer · 2023 · 13 citations

Psychological Co-morbidities, Psychiatry, Medicine +9

Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group

Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 12 citations · Full text

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

Çağlar Ünal, Abdulmunir Azizy, Senem Karabulut et al. · The Oncologist · 2023 · 10 citations · Full text